BR100 Increased By (0.86%)
BR30 Increased By (0.94%)
KSE100 Increased By (0.81%)
KSE30 Increased By (0.88%)
AGHA 6.47 Increased By ▲ 0.09 (1.41%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 62.50 Decreased By ▼ -0.05 (-0.08%)
BOP 31.51 Increased By ▲ 0.12 (0.38%)
CNERGY 11.81 Increased By ▲ 0.08 (0.68%)
CSIL 5.85 Decreased By ▼ -0.06 (-1.02%)
FCCL 61.89 Increased By ▲ 0.18 (0.29%)
FFL 15.03 Increased By ▲ 0.24 (1.62%)
FNEL 1.29 Increased By ▲ 0.05 (4.03%)
KEL 6.34 Increased By ▲ 0.02 (0.32%)
KOSM 5.82 Decreased By ▼ -0.08 (-1.36%)
LOTCHEM 24.90 Increased By ▲ 0.21 (0.85%)
MLCF 105.85 Increased By ▲ 1.92 (1.85%)
NBP 174.75 Increased By ▲ 1.43 (0.83%)
NCPL 52.11 Increased By ▲ 0.28 (0.54%)
NPL 54.61 Increased By ▲ 0.58 (1.07%)
OGDC 318.82 Increased By ▲ 2.95 (0.93%)
PACE 9.30 Increased By ▲ 0.04 (0.43%)
PAEL 35.85 Increased By ▲ 0.27 (0.76%)
PIBTL 14.23 Increased By ▲ 0.57 (4.17%)
PPL 229.00 Increased By ▲ 2.93 (1.3%)
PRL 81.70 Increased By ▲ 1.42 (1.77%)
PTC 47.00 Increased By ▲ 0.36 (0.77%)
SSGC 24.02 Increased By ▲ 0.20 (0.84%)
TBL 9.26 Increased By ▲ 0.02 (0.22%)
TELE 7.66 Increased By ▲ 0.11 (1.46%)
TPL 24.85 Increased By ▲ 0.31 (1.26%)
TPLP 12.95 Decreased By ▼ -0.04 (-0.31%)
TREET 26.00 Increased By ▲ 0.02 (0.08%)
TRG 53.74 Increased By ▲ 0.41 (0.77%)
By

FRANKFURT: Sanofi said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration case over claims by Boehringer Ingelheim that Sanofi should be liable for ongoing Zantac litigation in the United States.

The decision is final and can’t be appealed, the French drugmaker said in its statement.

Sanofi hones in on type 1 diabetes in $2.9bn Provention Bio deal

Boehringer said it had taken note of the arbitral tribunal’s decision and would not comment further.

Comments

Comments are closed for this article.